Clinical value of precision medicine in oncology: The tumour perspective
- At: 2016 FIP Congress in Buenos Aires (Argentina)
- Type: Presentation
- By: MCKINNON, Ross (Flinders University, Flinders University for Innovation in Cancer, Bedford Park, Australia)
- Co-author(s): Ross Mckinnon:|Michael J. Sorich:Clinical Pharmacology,Flinders University,Bedford Park,Australia
MTumour profiling is now routine in many countries although the extent of profiling is dependent on local health and economical imperatives. The aim of such profiling is to accelerate the implementation of precision medicine approaches thorough the identification of informative biomarkers that predict the efficacy and toxicity of treatment. Such.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.